CRP and Alzheimer disease: Since circulating native CRP levels increase dramatically during cardio/cerebrovascular events and mCRP is now known to become tissue and cell associated as a monomer with strong biological properties7, 10, 30, 34, it made sense to investigate if it could be involved in modulating cell signalling associated with plaque development or vascular damage associated with small vessel disease in AD affected individuals.